Form D · Pharmaceuticals
Illudent, Inc.
San Diego, CA · CIK 0001969039
Offering snapshot reported Aug 15, 2025 · SEC filing
- Reported sold
- $3.17M Offering amount: $4M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 12, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2025 | Initial | $3,174,994 | No comparison | 11 | SEC filing |
| Oct 23, 2023 | Amendment | $1,199,995 | $599,996vs Mar 17, 2023 | 16 | SEC filing |
| Mar 17, 2023 | Initial | $599,999 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-554971
Source: Form D, filed Aug 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joe Gatto | Director, Executive |
| Michael J. Kelner | Director, Executive |
| Clint Korver | Director |
| Shaun Lonergan | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6181 Cornerstone Court E Suite 104
San Diego, CA, 92121
Phone: 858-761-7733
San Diego, CA, 92121
Phone: 858-761-7733